TrialPloS one2015

A Multi-Center, Randomized, Controlled, Pivotal Study to Assess the Safety and Efficacy of a Selective Cytopheretic Device in Patients with Acute Kidney Injury.

James A Tumlin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.